🇺🇸 OXYTETRACYCLINE HYDROCHLORIDE in United States

FDA authorised OXYTETRACYCLINE HYDROCHLORIDE on 29 January 1964

Marketing authorisations

FDA — authorised 29 January 1964

  • Application: ANDA060869
  • Marketing authorisation holder: PROTER
  • Local brand name: OXYTETRACYCLINE HYDROCHLORIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 8 September 1964

  • Application: NDA050286
  • Marketing authorisation holder: PFIZER
  • Local brand name: TERRAMYCIN
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 9 August 1967

  • Application: ANDA060760
  • Marketing authorisation holder: IMPAX LABS
  • Local brand name: OXYTETRACYCLINE HYDROCHLORIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 11 August 1967

  • Application: ANDA060179
  • Marketing authorisation holder: FERRANTE
  • Local brand name: OXY-KESSO-TETRA
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 29 September 1967

  • Application: ANDA060770
  • Marketing authorisation holder: HIKMA
  • Local brand name: OXYTETRACYCLINE HYDROCHLORIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

FDA

  • Application: ANDA061009
  • Marketing authorisation holder: PFIZER
  • Local brand name: TERRAMYCIN-POLYMYXIN
  • Indication: TABLET — VAGINAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA060634
  • Marketing authorisation holder: PUREPAC PHARM
  • Local brand name: OXYTETRACYCLINE HYDROCHLORIDE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA060586
  • Marketing authorisation holder: PFIZER
  • Local brand name: TERRAMYCIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

OXYTETRACYCLINE HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is OXYTETRACYCLINE HYDROCHLORIDE approved in United States?

Yes. FDA authorised it on 29 January 1964; FDA authorised it on 8 September 1964; FDA authorised it on 9 August 1967.

Who is the marketing authorisation holder for OXYTETRACYCLINE HYDROCHLORIDE in United States?

PROTER holds the US marketing authorisation.